Seminal Biosciences produces specialty fats including cocoa butter alternatives via precision fermentation. The company is considering both B2B/B2C partnerships and potentially selling directly to customers through a chocolate product.
As of October 2023, the company had aimed to launch its cocoa butter alternative in a dark chocolate bar in 2024, with plans for additional products to replace animal fats in the pipeline.
Seminal Bio's yeast strain is claimed to rapidly convert sugar into fat, yielding approximately 60% of its body weight in fat.
Key customers and partnerships
In collaboration with Nucelis , a company focused on microbial fermentation strain development, Seminal Biosciences has developed a prototype for non-cacao bean-based cocoa butter using precision fermentation. As of October 2023, the two companies were refining the prototype in preparation for a market launch in 2024.
Funding and financials
Seminal Biosciences emerged from stealth mode in October 2022 and was in the process of raising seed funding as of October 2023.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.